2006 - PhD Cancer Biochemistry and Cell Biology, University of Cambridge
2001 - Bsc (1st Hons) Medical Biology, Brunel University
Dr March是癌症生物学家，主要研究领域是细胞信号传导和肠道肿瘤学。博士课题内容是研究MAP激酶通路对AP- 1蛋白的调节。目前任英国剑桥大学肿瘤研究所高级博士后研究员，工作重点是应用新模型来判定和表征大肠癌的新驱动基因。此前在英国Babraham研究所做博士后研究，工作内容是与UCB制药公司合作，研究癫痫药物的作用模式。另外还曾在生物技术行业工作。多次受邀在国内和国际上讲学，并在一些国际同行评审期刊发表过文章2011年初加入理文，担任编辑。
Dr March is a cancer biologist with special interests in cell signaling and intestinal oncology. Her PhD research examined the regulation of AP-1 proteins by MAP kinase pathways. Dr March is currently a Senior Postdoctoral Research Fellow at the Cancer Research UK Cambridge Research Institute, where her work focuses on the application of innovative models to identify and characterize novel driver genes in colorectal cancer. Previously, Dr March was a Postdoctoral Research Scientist at the Babraham Institute, UK, where, in collaboration with UCB Pharma, she studied the mode of action of an anti-epilepsy drug. She also has experience working in the biotechnology industry. Dr March has given invited lectures both nationally and internationally, and has published in several international peer-reviewed journals. Dr March joined Edanz as an editor in early 2011.
